Clinical trial NCT00220818 - References

Gastroesophageal Reflux Disease — A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.

Citation(s)

•   Springer M, Atkinson S, North J, Raanan M
  Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year. Paediatr Drugs. 2008;10(4):255-63.
•   Zhang W, Kukulka M, Witt G, Sutkowski-Markmann D, North J, Atkinson S
  Age-dependent pharmacokinetics of lansoprazole in neonates and infants. Paediatr Drugs. 2008;10(4):265-74.

A Phase 1, Single- and Repeated-Dose, Randomized, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Infants With Clinically-Evident Gastroesophageal Reflux Disease.

Details for clinical trial NCT00220818